STOCK TITAN

[8-K] Truist Financial Corporation Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Gevo, Inc. has filed a Form 144 indicating a proposed sale of 43,964 common shares through broker Stifel Nicolaus on or about 01 Aug 2025. The shares carry an estimated aggregate market value of $49,472, implying a price near $1.13 and amounting to just 0.018 % of the company’s 239.6 million shares outstanding, suggesting minimal dilution or control impact. The seller attests that no material non-public adverse information exists.

The filer acquired 78,237 restricted stock units on 26 Jul 2025 and, in the past three months, sold 73,934 shares on 30 May 2025 for $94,783. While the notice may hint at continued insider monetisation, the absolute size and relative stake are immaterial to the capital structure and market liquidity.

Gevo, Inc. ha presentato un Modulo 144 relativo a una proposta di vendita di 43.964 azioni ordinarie tramite il broker Stifel Nicolaus intorno al 01 agosto 2025. Le azioni hanno un valore di mercato aggregato stimato di 49.472 $, con un prezzo approssimativo di 1,13 $, rappresentando solo lo 0,018% delle 239,6 milioni di azioni in circolazione, indicando un impatto minimo su diluizione o controllo. Il venditore dichiara che non esistono informazioni riservate negative rilevanti.

Il soggetto che ha presentato la comunicazione ha acquisito 78.237 unità azionarie vincolate il 26 luglio 2025 e, negli ultimi tre mesi, ha venduto 73.934 azioni il 30 maggio 2025 per 94.783 $. Sebbene l’avviso possa suggerire una continua monetizzazione interna, la dimensione assoluta e la quota relativa sono irrilevanti per la struttura del capitale e la liquidità di mercato.

Gevo, Inc. ha presentado un Formulario 144 indicando una propuesta de venta de 43,964 acciones comunes a través del corredor Stifel Nicolaus aproximadamente el 01 de agosto de 2025. Las acciones tienen un valor de mercado agregado estimado de $49,472, lo que implica un precio cercano a $1.13 y representan solo el 0.018 % de las 239.6 millones de acciones en circulación, sugiriendo un impacto mínimo en la dilución o control. El vendedor afirma que no existe información adversa material no pública.

El declarante adquirió 78,237 unidades restringidas de acciones el 26 de julio de 2025 y, en los últimos tres meses, vendió 73,934 acciones el 30 de mayo de 2025 por $94,783. Aunque el aviso podría indicar una monetización interna continua, el tamaño absoluto y la participación relativa son insignificantes para la estructura de capital y la liquidez del mercado.

Gevo, Inc.는 중개인 Stifel Nicolaus를 통해 2025년 8월 1일경 43,964 보통주 매각 제안을 나타내는 Form 144를 제출했습니다. 해당 주식의 추정 총 시장 가치는 49,472달러로, 주당 가격은 약 1.13달러이며, 회사의 총 발행 주식 2억 3,960만 주 중 0.018%에 해당해 희석화나 경영권에 미치는 영향이 미미함을 시사합니다. 판매자는 중요한 비공개 부정적 정보가 없음을 확인했습니다.

신고자는 2025년 7월 26일에 78,237 제한 주식 단위를 취득했으며, 최근 3개월 내에 2025년 5월 30일에 73,934주94,783달러에 매각했습니다. 이 공지는 내부자 자산 현금화가 계속될 가능성을 암시할 수 있지만, 절대 규모와 상대 지분은 자본 구조와 시장 유동성에 큰 영향을 미치지 않습니다.

Gevo, Inc. a déposé un formulaire 144 indiquant une vente proposée de 43 964 actions ordinaires via le courtier Stifel Nicolaus aux alentours du 1er août 2025. Les actions ont une valeur de marché agrégée estimée à 49 472 $, ce qui implique un prix proche de 1,13 $ et représente seulement 0,018 % des 239,6 millions d’actions en circulation, suggérant un impact minimal sur la dilution ou le contrôle. Le vendeur atteste qu’aucune information négative matérielle non publique n’existe.

Le déclarant a acquis 78 237 unités d’actions restreintes le 26 juillet 2025 et, au cours des trois derniers mois, a vendu 73 934 actions le 30 mai 2025 pour 94 783 $. Bien que l’avis puisse suggérer une monétisation continue par les initiés, la taille absolue et la participation relative sont insignifiantes pour la structure du capital et la liquidité du marché.

Gevo, Inc. hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 43.964 Stammaktien über den Broker Stifel Nicolaus etwa am 01. August 2025 ankündigt. Die Aktien haben einen geschätzten Gesamtmarktwert von 49.472 $, was auf einen Preis von etwa 1,13 $ hindeutet und nur 0,018 % der 239,6 Millionen ausstehenden Aktien des Unternehmens ausmacht, was auf eine minimale Verwässerung oder Kontrolle hinweist. Der Verkäufer bestätigt, dass keine wesentlichen nicht öffentlichen negativen Informationen vorliegen.

Der Einreicher erwarb am 26. Juli 2025 78.237 eingeschränkte Aktienanteile und verkaufte in den letzten drei Monaten am 30. Mai 2025 73.934 Aktien für 94.783 $. Obwohl die Mitteilung auf eine fortgesetzte Insider-Monetarisierung hindeuten könnte, sind die absolute Größe und der relative Anteil für die Kapitalstruktur und Marktliquidität unerheblich.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small Form 144 for 44k GEVO shares; dollar value trivial, unlikely to move stock, but signals incremental insider selling trend.

The proposed 43,964-share disposition is worth under $50k and equals less than two-hundredths of one percent of shares outstanding. Such volume should not create meaningful supply pressure nor affect voting power. However, it extends a pattern: the same insider sold ~74k shares two months earlier. Persistent insider selling—even at modest scale—can influence sentiment in a cash-burning, early-stage biofuels company like Gevo. From a governance lens, the certification that no undisclosed negative information exists reduces information-asymmetry concerns. Overall, the filing is not materially impactful but merits monitoring if cumulative insider dispositions accelerate.

Gevo, Inc. ha presentato un Modulo 144 relativo a una proposta di vendita di 43.964 azioni ordinarie tramite il broker Stifel Nicolaus intorno al 01 agosto 2025. Le azioni hanno un valore di mercato aggregato stimato di 49.472 $, con un prezzo approssimativo di 1,13 $, rappresentando solo lo 0,018% delle 239,6 milioni di azioni in circolazione, indicando un impatto minimo su diluizione o controllo. Il venditore dichiara che non esistono informazioni riservate negative rilevanti.

Il soggetto che ha presentato la comunicazione ha acquisito 78.237 unità azionarie vincolate il 26 luglio 2025 e, negli ultimi tre mesi, ha venduto 73.934 azioni il 30 maggio 2025 per 94.783 $. Sebbene l’avviso possa suggerire una continua monetizzazione interna, la dimensione assoluta e la quota relativa sono irrilevanti per la struttura del capitale e la liquidità di mercato.

Gevo, Inc. ha presentado un Formulario 144 indicando una propuesta de venta de 43,964 acciones comunes a través del corredor Stifel Nicolaus aproximadamente el 01 de agosto de 2025. Las acciones tienen un valor de mercado agregado estimado de $49,472, lo que implica un precio cercano a $1.13 y representan solo el 0.018 % de las 239.6 millones de acciones en circulación, sugiriendo un impacto mínimo en la dilución o control. El vendedor afirma que no existe información adversa material no pública.

El declarante adquirió 78,237 unidades restringidas de acciones el 26 de julio de 2025 y, en los últimos tres meses, vendió 73,934 acciones el 30 de mayo de 2025 por $94,783. Aunque el aviso podría indicar una monetización interna continua, el tamaño absoluto y la participación relativa son insignificantes para la estructura de capital y la liquidez del mercado.

Gevo, Inc.는 중개인 Stifel Nicolaus를 통해 2025년 8월 1일경 43,964 보통주 매각 제안을 나타내는 Form 144를 제출했습니다. 해당 주식의 추정 총 시장 가치는 49,472달러로, 주당 가격은 약 1.13달러이며, 회사의 총 발행 주식 2억 3,960만 주 중 0.018%에 해당해 희석화나 경영권에 미치는 영향이 미미함을 시사합니다. 판매자는 중요한 비공개 부정적 정보가 없음을 확인했습니다.

신고자는 2025년 7월 26일에 78,237 제한 주식 단위를 취득했으며, 최근 3개월 내에 2025년 5월 30일에 73,934주94,783달러에 매각했습니다. 이 공지는 내부자 자산 현금화가 계속될 가능성을 암시할 수 있지만, 절대 규모와 상대 지분은 자본 구조와 시장 유동성에 큰 영향을 미치지 않습니다.

Gevo, Inc. a déposé un formulaire 144 indiquant une vente proposée de 43 964 actions ordinaires via le courtier Stifel Nicolaus aux alentours du 1er août 2025. Les actions ont une valeur de marché agrégée estimée à 49 472 $, ce qui implique un prix proche de 1,13 $ et représente seulement 0,018 % des 239,6 millions d’actions en circulation, suggérant un impact minimal sur la dilution ou le contrôle. Le vendeur atteste qu’aucune information négative matérielle non publique n’existe.

Le déclarant a acquis 78 237 unités d’actions restreintes le 26 juillet 2025 et, au cours des trois derniers mois, a vendu 73 934 actions le 30 mai 2025 pour 94 783 $. Bien que l’avis puisse suggérer une monétisation continue par les initiés, la taille absolue et la participation relative sont insignifiantes pour la structure du capital et la liquidité du marché.

Gevo, Inc. hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 43.964 Stammaktien über den Broker Stifel Nicolaus etwa am 01. August 2025 ankündigt. Die Aktien haben einen geschätzten Gesamtmarktwert von 49.472 $, was auf einen Preis von etwa 1,13 $ hindeutet und nur 0,018 % der 239,6 Millionen ausstehenden Aktien des Unternehmens ausmacht, was auf eine minimale Verwässerung oder Kontrolle hinweist. Der Verkäufer bestätigt, dass keine wesentlichen nicht öffentlichen negativen Informationen vorliegen.

Der Einreicher erwarb am 26. Juli 2025 78.237 eingeschränkte Aktienanteile und verkaufte in den letzten drei Monaten am 30. Mai 2025 73.934 Aktien für 94.783 $. Obwohl die Mitteilung auf eine fortgesetzte Insider-Monetarisierung hindeuten könnte, sind die absolute Größe und der relative Anteil für die Kapitalstruktur und Marktliquidität unerheblich.

0000092230FALSE--12-3100000922302025-07-292025-07-290000092230us-gaap:CommonStockMember2025-07-292025-07-290000092230tfc:SeriesIPreferredStockMember2025-07-292025-07-290000092230tfc:SeriesJPreferredStockMember2025-07-292025-07-290000092230tfc:SeriesOPreferredStockMember2025-07-292025-07-290000092230tfc:SeriesRPreferredStockMember2025-07-292025-07-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
Form 8-K
Current Report
_____________________________

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

July 29, 2025
Date of Report (Date of earliest event reported)

Truist Financial Corporation
(Exact name of registrant as specified in its charter)
_____________________________
North Carolina
1-10853
56-0939887
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
214 North Tryon Street
Charlotte,
North Carolina
28202
(Address of principal executive offices)
(Zip Code)

(844) 487-8478
(Registrant's telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $5 par valueTFCNew York Stock Exchange
Depositary Shares each representing 1/4,000th interest in a share of Series I Perpetual Preferred StockTFC.PINew York Stock Exchange
5.853% Fixed-to-Floating Rate Normal Preferred Purchase Securities each representing 1/100th interest in a share of Series J Perpetual Preferred StockTFC.PJNew York Stock Exchange
Depositary Shares each representing 1/1,000th interest in a share of Series O Non-Cumulative Perpetual Preferred StockTFC.PONew York Stock Exchange
Depositary Shares each representing 1/1,000th interest in a share of Series R Non-Cumulative Perpetual Preferred StockTFC.PRNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 


ITEM 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On July 29, 2025, the Board of Directors of Truist Financial Corporation (“Truist”) approved and adopted, effective as of such date, amendments to Truist’s Amended and Restated Bylaws (as so amended, the “Bylaws”). Capitalized terms used and not defined herein have the meanings assigned to such terms in the Bylaws.

The amendments to the Bylaws consist primarily of revisions and clarifications to certain procedural and disclosure requirements for shareholder proposals and director nominations, including the information that must be provided in connection with such a proposal or director nomination.

Specifically, the amendments to the Bylaws include, among other things:

a.Amending Article II, Section 10 to enhance disclosure requirements for shareholders intending to nominate directors or propose other business at meetings of the shareholders and for proposed director nominees;
b.Revising Article III to, among other things:
i.provide that a director will not be nominated for a term that would begin in the calendar year after the one in which the director turns 75 years of age; and
ii.provide additional flexibility in the creation, composition, and structuring of standing or special committees of the Board;
c.Amending Article IV, Section 2 to provide that the Lead Independent Director may call special meetings of the Board;
d.Amending Article IV, Section 6 to provide that the Lead Independent Director (or such other independent director designated by the Lead Independent Director or, if no designee exists, an independent director selected at the time by a majority of the independent directors) will preside at all meetings of the Board if the Chairman of the Board requests, is not present, or has a conflict;
e.Revising Article IV, Section 8 to clarify the manner in which Board action without a meeting is taken and revoked;
f.Revising Article V, Section 4 to clarify the parties empowered to fix officer compensation; and
g.Revising Article VI to remove various provisions related to Board oversight of contracts, loans, and deposits in order to better align with Truist’s corporate practices.

Finally, the amendments to the Bylaws contain updates to conform to the North Carolina Business Corporation Act as well as several non-substantive, ministerial, clarifying, and conforming changes.

The foregoing summary is qualified in its entirety by reference to the Bylaws, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

ITEM 9.01    Financial Statements and Exhibits.
(d)    Exhibits.
Exhibit No.Description
3.1
Bylaws of Truist Financial Corporation, as Amended and Restated, Effective July 29, 2025.
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TRUIST FINANCIAL CORPORATION
(Registrant)
By:/s/ Cynthia B. Powell
Cynthia B. Powell
Executive Vice President and Corporate Controller
(Principal Accounting Officer)

Date: August 1, 2025

FAQ

How many GEVO shares are covered by the new Form 144 filing?

The notice covers 43,964 common shares of Gevo, Inc.

When is the anticipated sale date for the GEVO shares?

The filing lists an approximate sale date of 01 Aug 2025.

What percentage of Gevo’s outstanding shares does the planned sale represent?

The 43,964 shares equal roughly 0.018 % of the 239.6 million shares outstanding.

Which broker will execute the proposed GEVO share sale?

Stifel Nicolaus & Company, Inc., located at 501 N Broadway, St. Louis, MO 63102.

Were there recent insider sales preceding this filing?

Yes. The filer sold 73,934 shares on 30 May 2025 for $94,783.
Truist Finl Corp

NYSE:TFC

TFC Rankings

TFC Latest News

TFC Latest SEC Filings

TFC Stock Data

57.07B
1.29B
0.22%
78.75%
1.73%
Banks - Regional
National Commercial Banks
Link
United States
CHARLOTTE